+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Erectile Dysfunction Market - Global Forecast 2026-2032- Product Image
Erectile Dysfunction Market - Global Forecast 2026-2032- Product Image
Sale

Erectile Dysfunction Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6121721
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Erectile Dysfunction Market is projected to reach USD 13.82 Billion in 2026. It is expected to continue growing at a CAGR of 4.70%, reaching USD 18.10 Billion by 2032.

Erectile Dysfunction: Executive Summary and Market Context

Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It is a common condition associated with aging, cardiovascular disease, diabetes, obesity, neurological disorders, medication use, psychological factors, and relationship or lifestyle issues. Because ED can precede the recognition of broader vascular disease, clinical evaluation increasingly emphasizes underlying health rather than symptom management alone. Diagnosis typically combines medical and sexual history, medication review, physical examination, and selective laboratory testing, while treatment may include lifestyle changes, counseling, oral therapies, devices, injections, or surgery according to patient needs and clinical suitability.

Care Is Shifting Toward Integrated, Patient-Centered ED Management

The treatment landscape is moving from episodic prescribing toward integrated management of sexual, cardiovascular, metabolic, and psychological health. Greater awareness of ED as a potential marker of vascular dysfunction is encouraging risk-factor assessment and coordination among primary-care clinicians, urologists, endocrinologists, and mental-health professionals. Patient expectations are also reshaping care: discreet access, shared decision-making, transparent safety information, and treatment options that fit relationships and daily routines are increasingly important. Telemedicine and digital intake tools can improve convenience, but they require robust identity verification, medical screening, privacy safeguards, and continuity of care.

Artificial Intelligence Can Improve Screening, Triage, and Personalization

Artificial intelligence can support ED care by organizing symptom histories, identifying medication or comorbidity patterns, assisting clinical triage, and helping clinicians recognize patients who may warrant cardiovascular or endocrine evaluation. Digital tools may also enable more personalized education and adherence support. However, AI should remain assistive rather than autonomous: training data may underrepresent older adults, minority populations, and patients with complex comorbidities; sensitive sexual-health information requires heightened protection; and recommendations must be clinically validated, explainable, and subject to human oversight. Responsible deployment depends on bias monitoring, secure data governance, informed consent, and clear escalation pathways for urgent or specialist care.

Regional Insights: Access, Regulation, and Health-System Capacity Shape ED Care

North America generally combines broad treatment availability with high demand for confidential, convenient services, although affordability and insurance coverage can influence access. Latin America faces uneven specialist distribution and differences in medicine availability, making primary-care education and regulated telehealth important. Europe benefits from established urological services and coordinated public-health systems, while reimbursement rules and national clinical pathways vary. The Middle East is characterized by differing regulatory environments, cultural sensitivities, and growing interest in discreet, medically supervised care. Africa has substantial unmet needs linked to limited specialist capacity, diagnostic access, and medicine quality assurance. Asia-Pacific spans highly developed systems and resource-constrained settings, creating a strong need for culturally appropriate counseling, chronic-disease integration, and scalable primary-care solutions.

Group Insights: Regional Alliances Create Different Policy and Access Priorities

ASEAN members face varied healthcare infrastructure, regulatory systems, and cultural attitudes, favoring adaptable education, pharmacy standards, and referral models. BRICS countries represent diverse disease burdens and health-system capacities, with opportunities to strengthen affordable diagnosis, chronic-disease management, and local clinical expertise. The European Union benefits from shared regulatory principles while retaining national differences in reimbursement and service delivery. G7 systems generally have strong clinical capacity but must address aging populations, multimorbidity, privacy, and equitable access. GCC countries can leverage concentrated healthcare investment while continuing to build culturally sensitive sexual-health services. NATO members span different public and private systems, making consistent clinical education, medicine quality, and service continuity relevant across varied national contexts.

Country Insights: National Health Priorities Influence ED Diagnosis and Treatment

Australia has strong primary-care and specialist capabilities, with opportunities to improve proactive cardiovascular assessment and rural access. Brazil and Mexico require approaches that address regional disparities, affordability, and regulated access to qualified providers. Canada’s publicly oriented system supports integrated chronic-disease care, although timely specialist access can differ by geography. China and India need scalable, culturally sensitive services that connect ED management with diabetes, hypertension, and mental-health care. France, Germany, Italy, Spain, and the United Kingdom have established clinical infrastructure, but reimbursement, referral pathways, and privacy expectations differ across systems. Japan and South Korea have advanced healthcare capabilities alongside aging-related demand and the need for less stigmatizing consultation models. Russia faces the importance of medicine quality, specialist access, and reliable clinical oversight. Across the United States, fragmented coverage and high digital adoption make affordability, evidence-based telehealth, and coordinated cardiovascular evaluation central concerns.

Action Priorities for Leaders: Build Trusted, Integrated, and Equitable ED Services

Industry leaders should align ED services with broader cardiometabolic and mental-health pathways rather than treating the condition in isolation. Priority actions include strengthening clinician education, using standardized safety screening, expanding confidential access through appropriately governed telehealth, and ensuring referral mechanisms for cardiovascular, endocrine, neurological, and psychological conditions. Organizations should provide clear patient information on contraindications, interactions, expected outcomes, and alternatives; monitor treatment adherence and adverse events; and design services for older adults, rural populations, and groups historically underserved by sexual-health care. Digital and AI investments should be accompanied by validation, cybersecurity, auditability, and human review. Partnerships with health systems and regulators can improve quality assurance, medicine authenticity, and continuity of care.

Research Methodology: Evidence-Based Synthesis of Clinical and Health-System Factors

This executive summary uses a structured, qualitative synthesis of established clinical concepts relevant to ED, including recognized risk factors, diagnostic practice, treatment modalities, healthcare delivery, digital health, and responsible AI. Regional, group, and country observations are framed as contextual comparisons of health-system capacity, regulation, access, demographics, and cultural considerations rather than quantitative market claims. The analysis avoids market estimates, forecasts, company-specific assessments, and unsupported numerical conclusions. Interpretations should be validated against current national guidelines, regulatory requirements, epidemiological evidence, reimbursement policies, and local clinical practice before operational decisions are made.

Conclusion: Treat ED as Both a Sexual-Health Need and a Broader Clinical Signal

ED care is increasingly defined by integration: effective support should address sexual function while considering cardiovascular, metabolic, neurological, psychological, and relationship factors. Regional and national differences mean that successful services must be clinically rigorous, culturally competent, affordable, and accessible through trusted channels. AI and telehealth can extend reach and improve personalization when implemented with strong safeguards, but neither replaces professional judgment. Leaders who prioritize coordinated evaluation, patient privacy, medicine quality, and equitable access will be better positioned to improve outcomes and reduce the stigma surrounding ED.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Erectile Dysfunction Market, by Product Type
7.1. Introduction
7.2. Device
7.2.1. Penile Implants
7.2.2. Penile Injections
7.2.3. Vacuum Erection Devices
7.3. Drug
7.3.1. Avanafil
7.3.2. Sildenafil
7.3.3. Tadalafil
8. Erectile Dysfunction Market, by Treatment Type
8.1. Introduction
8.2. Oral Agents
8.3. Penile Implants
8.4. Penile Injections
8.5. Vacuum Erection Devices
9. Erectile Dysfunction Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Erectile Dysfunction Market, by Patient Age Group
10.1. Introduction
10.2. 40-49
10.3. 50-59
10.4. 60-69
10.5. 70+
11. Erectile Dysfunction Market, by Distribution Channel
11.1. Introduction
11.2. Clinic Pharmacy
11.3. Hospital Pharmacy
11.4. Online Pharmacy
11.5. Retail Pharmacy
12. Erectile Dysfunction Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Homecare
12.4. Hospitals
13. Erectile Dysfunction Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Erectile Dysfunction Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Erectile Dysfunction Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Bayer AG
17.2. Boston Scientific Corporation
17.3. Cipla Limited
17.4. Coloplast Group
17.5. Dong A Socio Holdings Co. Ltd.
17.6. Dr. Reddy's Laboratories Ltd.
17.7. Eli Lilly and Company
17.8. Endo International Plc
17.9. Futura Medical Plc
17.10. GlaxoSmithKline plc
17.11. Lupin Limited
17.12. Pfizer Inc.
17.13. Sandoz International GmbH
17.14. Sanofi S.A.
17.15. Sun Pharmaceutical Industries Ltd.
17.16. Teva Pharmaceutical Industries Ltd.
17.17. Viatris Inc.
17.18. Vivus, Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Erectile Dysfunction Market, Years Considered for the Study
FIGURE 2. Global Erectile Dysfunction Market, Research Design
FIGURE 3. Global Erectile Dysfunction Market, Research Framework
FIGURE 4. Global Erectile Dysfunction Market, Data Triangulation
FIGURE 5. Global Erectile Dysfunction Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Erectile Dysfunction Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Erectile Dysfunction Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Erectile Dysfunction Market Size, by Treatment Type, 2025 vs 2032 (%)
FIGURE 9. Global Erectile Dysfunction Market Size, by Treatment Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Erectile Dysfunction Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Erectile Dysfunction Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Erectile Dysfunction Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 13. Global Erectile Dysfunction Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Erectile Dysfunction Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Erectile Dysfunction Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Erectile Dysfunction Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Erectile Dysfunction Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Erectile Dysfunction Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Erectile Dysfunction Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Erectile Dysfunction Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Erectile Dysfunction Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Erectile Dysfunction Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Erectile Dysfunction Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Erectile Dysfunction Market Segmentation & Coverage
TABLE 2. Global Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 3. Global Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Penile Implants Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Penile Implants Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Penile Implants Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Penile Injections Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Penile Injections Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Penile Injections Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Vacuum Erection Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Vacuum Erection Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Vacuum Erection Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Drug Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Drug Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Drug Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Avanafil Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Avanafil Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Avanafil Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Sildenafil Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Sildenafil Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Sildenafil Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Tadalafil Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Tadalafil Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Tadalafil Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 29. Global Oral Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Oral Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Oral Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Penile Implants Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Penile Implants Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Penile Implants Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Penile Injections Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Penile Injections Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Penile Injections Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Vacuum Erection Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Vacuum Erection Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Vacuum Erection Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 42. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 52. Global 40-49 Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global 40-49 Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global 40-49 Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global 50-59 Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global 50-59 Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global 50-59 Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global 60-69 Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global 60-69 Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global 60-69 Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global 70+ Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global 70+ Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global 70+ Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 65. Global Clinic Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Clinic Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Clinic Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Homecare Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Homecare Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Homecare Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Erectile Dysfunction Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Erectile Dysfunction Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. North America Erectile Dysfunction Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. North America Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. North America Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 100. North America Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 101. North America Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 102. North America Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 103. North America Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 104. North America Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. North America Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. Latin America Erectile Dysfunction Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Latin America Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Latin America Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 109. Latin America Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 110. Latin America Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 111. Latin America Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 112. Latin America Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 113. Latin America Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. Latin America Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Europe Erectile Dysfunction Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Europe Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. Europe Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 118. Europe Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 119. Europe Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 120. Europe Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 121. Europe Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 122. Europe Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. Europe Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Middle East Erectile Dysfunction Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Middle East Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. Middle East Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 127. Middle East Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 128. Middle East Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 129. Middle East Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 130. Middle East Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 131. Middle East Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. Middle East Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Africa Erectile Dysfunction Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Africa Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. Africa Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 136. Africa Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 137. Africa Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 138. Africa Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 139. Africa Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 140. Africa Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. Africa Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Global Erectile Dysfunction Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. ASEAN Erectile Dysfunction Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. ASEAN Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. ASEAN Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 146. ASEAN Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 147. ASEAN Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 148. ASEAN Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 149. ASEAN Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 150. ASEAN Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. ASEAN Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. GCC Erectile Dysfunction Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. GCC Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. GCC Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 155. GCC Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 156. GCC Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 157. GCC Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 158. GCC Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 159. GCC Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. GCC Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. European Union Erectile Dysfunction Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. European Union Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. European Union Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 164. European Union Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 165. European Union Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 166. European Union Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 167. European Union Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 168. European Union Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. European Union Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. BRICS Erectile Dysfunction Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. BRICS Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. BRICS Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 173. BRICS Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 174. BRICS Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 175. BRICS Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 176. BRICS Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 177. BRICS Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. BRICS Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. G7 Erectile Dysfunction Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. G7 Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. G7 Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 182. G7 Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 183. G7 Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 184. G7 Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 185. G7 Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 186. G7 Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 187. G7 Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. NATO Erectile Dysfunction Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. NATO Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. NATO Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 191. NATO Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 192. NATO Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 193. NATO Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 194. NATO Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 195. NATO Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. NATO Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Global Erectile Dysfunction Market Size, by Country, 2017-2032 (USD Million)
TABLE 198. United States Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 199. United States Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. United States Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 201. United States Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 202. United States Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 203. United States Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 204. United States Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 205. United States Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. United States Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Canada Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 208. Canada Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. Canada Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 210. Canada Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 211. Canada Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 212. Canada Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 213. Canada Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 214. Canada Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. Canada Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Mexico Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 217. Mexico Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Mexico Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 219. Mexico Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 220. Mexico Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 221. Mexico Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 222. Mexico Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 223. Mexico Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Mexico Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Brazil Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 226. Brazil Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. Brazil Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 228. Brazil Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 229. Brazil Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 230. Brazil Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 231. Brazil Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 232. Brazil Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 233. Brazil Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. United Kingdom Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 235. United Kingdom Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 236. United Kingdom Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 237. United Kingdom Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 238. United Kingdom Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 239. United Kingdom Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 240. United Kingdom Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 241. United Kingdom Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. United Kingdom Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Germany Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 244. Germany Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. Germany Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 246. Germany Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 247. Germany Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 248. Germany Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 249. Germany Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 250. Germany Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. Germany Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. France Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 253. France Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. France Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 255. France Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 256. France Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 257. France Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 258. France Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 259. France Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. France Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Russia Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 262. Russia Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 263. Russia Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 264. Russia Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 265. Russia Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 266. Russia Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 267. Russia Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 268. Russia Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 269. Russia Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Italy Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 271. Italy Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. Italy Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 273. Italy Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 274. Italy Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 275. Italy Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 276. Italy Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 277. Italy Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 278. Italy Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Spain Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 280. Spain Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 281. Spain Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 282. Spain Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 283. Spain Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 284. Spain Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 285. Spain Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 286. Spain Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 287. Spain Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 288. China Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 289. China Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 290. China Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 291. China Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 292. China Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 293. China Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 294. China Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 295. China Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 296. China Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. India Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 298. India Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. India Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 300. India Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 301. India Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 302. India Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 303. India Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 304. India Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 305. India Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. Japan Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 307. Japan Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 308. Japan Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 309. Japan Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 310. Japan Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 311. Japan Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 312. Japan Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 313. Japan Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 314. Japan Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. Australia Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 316. Australia Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 317. Australia Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 318. Australia Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 319. Australia Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 320. Australia Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 321. Australia Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 322. Australia Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 323. Australia Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. South Korea Erectile Dysfunction Market Size, 2017-2032 (USD Million)
TABLE 325. South Korea Erectile Dysfunction Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 326. South Korea Erectile Dysfunction Market Size, by Device, 2017-2032 (USD Million)
TABLE 327. South Korea Erectile Dysfunction Market Size, by Drug, 2017-2032 (USD Million)
TABLE 328. South Korea Erectile Dysfunction Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 329. South Korea Erectile Dysfunction Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 330. South Korea Erectile Dysfunction Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 331. South Korea Erectile Dysfunction Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 332. South Korea Erectile Dysfunction Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. Global Erectile Dysfunction Market Share, by Key Player, 2025
TABLE 334. Global Erectile Dysfunction Market, Key Experts

Companies Mentioned

  • Bayer AG
  • Boston Scientific Corporation
  • Cipla Limited
  • Coloplast Group
  • Dong A Socio Holdings Co. Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Endo International Plc
  • Futura Medical Plc
  • GlaxoSmithKline plc
  • Lupin Limited
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Vivus, Inc.

Related Topics

Related Reports

Erectile Dysfunction Drugs Market - Global Forecast 2026-2032 - Product Image

Erectile Dysfunction Drugs Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Erectile Dysfunction Drugs - Global Strategic Business Report - Product Image

Erectile Dysfunction Drugs - Global Strategic Business Report

  • Report
  • 287 Pages
  • Global
From
Erectile Dysfunction - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Image

Erectile Dysfunction - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Erectile Dysfunction Drug Pipeline Analysis Report 2026 - Product Image

Erectile Dysfunction Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • 150 Pages
  • Global
From
Drugs for Erectile Dysfunction Market Report 2026 - Product Image

Drugs for Erectile Dysfunction Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.